1 2013 (as of 20130312) Cortés-González JR, Castellanos E

1
2013 (as of 20130312)
Cortés-González JR, Castellanos E, Sandberg K, Eriksson MH, Wiklund P, Carlsson S, CohnCedermark G, Harmenberg U, Gustafsson O, Levitt SH, Lennernäs B, Brandberg Y, Márquez
M, Kälkner KM, Nilsson S. Int J Oncol. 2013 Jan;42(1):109-17. Early salvage radiation
therapy combined with short-term hormonal therapy in recurrent prostate cancer after radical
prostatectomy: single-institution 4-year data on outcome, toxicity, health-related quality of
life and co-morbidities from 184 consecutive patients treated with 70 Gy.
Arraras JI, Greimel E, Chie WC, Sezer O, Bergenmar M, Costantini A, Young T, Vlasic KK,
Velikova G; European Organisation for Research and Treatment of Cancer Quality of Life
Group. Psychooncology. 2013 Feb;22(2):268-75. Cross-cultural differences in information
disclosure evaluated through the EORTC questionnaires.
Hjerpe E, Egyhazi S, Carlson J, Stolt MF, Schedvins K, Johansson H, Shoshan M, AvallLundqvist E. Int J Gynecol Cancer. 2013 Mar;23(3):448-55. HSP60 Predicts Survival in
Advanced Serous Ovarian Cancer.
Patlazhan G, Unukovych D, Pshenisnov K. Aesthetic Plast Surg. 2013 Feb 5. DOI:
10.1007/s00266-012-0045-5. Breast Reconstruction and Treatment Algorithm for Patients
with Complications after Polyacrylamide Gel Injections: A 10-Year Experience.
Hellman K, Johansson H, Andersson S, Pettersson F, Auer G. Int J Gynecol Cancer. 2013
Jan;23(1):41-51. Prognostic significance of cell cycle- and invasion-related molecular
markers and genomic instability in primary carcinoma of the vagina.
Fahlén M, Fornander T, Johansson H, Johansson U, Rutqvist LE, Wilking N, von Schoultz E.
Eur J Cancer. 2013 Jan;49(1):52-9. Hormone replacement therapy after breast cancer: 10 year
follow up of the Stockholm randomised trial.
2012
Kasparian NA, Bränström R, Chang YM, Affleck P, Aspinwall LG, Tibben A, Azizi E,
Baron-Epel O, Battistuzzi L, Bruno W, Chan M, Cuellar F, Debniak T, Pjanova D, Ertmanski
S, Figl A, Gonzalez M, Hayward NK, Hocevar M, Kanetsky PA, Leachman S, Bergman W,
Heisele O, Palmer J, Peric B, Puig S, Schadendorf D, Gruis NA, Newton-Bishop J, Brandberg
Y; Melanoma Genetics Consortium (GenoMEL). Arch Dermatol. 2012 Oct;148(10):1142-51.
Skin examination behavior: the role of melanoma history, skin type, psychosocial factors, and
region of residence in determining clinical and self-conducted skin examination.
Bränström R, Kasparian NA, Affleck P, Tibben A, Chang YM, Azizi E, Baron-Epel O,
Bergman W, Chan M, Davies J, Ingvar C, Kanetsky PA, van Leeuwen E, Olsson H, Gruis
NA, Brandberg Y, Newton-Bishop J. Eur J Cancer. 2012 Nov;48(16):3052-62. Perceptions of
genetic research and testing among members of families with an increased risk of malignant
melanoma.
Unukovych D, Sandelin K, Liljegren A, Arver B, Wickman M, Johansson H, Brandberg Y.
Eur J Cancer. 2012 Nov;48(17):3150-6. Contralateral prophylactic mastectomy in breast
2
cancer patients with a family history: a prospective 2-years follow-up study of health related
quality of life, sexuality and body image.
Unukovych D, Sandelin K, Wickman M, Arver B, Johansson H, Brandberg Y, Liljegren A.
Acta Oncol. 2012 Sep;51(7):934-41. Breast reconstruction in patients with personal and
family history of breast cancer undergoing contralateral prophylactic mastectomy, a 10-year
experience.
Platten U, Rantala J, Lindblom A, Brandberg Y, Lindgren G, Arver B. Fam Cancer. 2012
Sep;11(3):371-9. The use of telephone in genetic counseling versus in-person counseling: a
randomized study on counselees' outcome.
Brændengen M, Tveit KM, Hjermstad MJ, Johansson H, Berglund Å, Brandberg Y, Glimelius
B. Eur J Cancer. 2012 Apr;48(6):813-9. Health-related quality of life (HRQoL) after
multimodal treatment for primarily non-resectable rectal cancer. Long-term results from a
phase III study.
Svensson H, Hatschek T, Johansson H, Einbeigi Z, Brandberg Y. Med Oncol. 2012
Jun;29(2):432-8. Health-related quality of life as prognostic factor for response, progressionfree survival, and survival in women with metastatic breast cancer.
Sharp L, Finnilä K, Johansson H, Abrahamsson M, Hatschek T, Bergenmar M.
Eur J Oncol Nurs. 2012 Dec 12. [Epub ahead of print]. No differences between Calendula
cream and aqueous cream in the prevention of acute radiation skin reactions - Results from a
randomised blinded trial.
Hjermstad MJ, Bergenmar M, Fisher SE, Montel S, Nicolatou-Galitis O, Raber-Durlacher J,
Singer S, Verdonck-de Leeuw I, Weis J, Yarom N, Herlofson BB. Eur J Cancer. 2012
Sep;48(14):2203-11. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQC30 for assessment of oral health and quality of life in cancer patients.
Näsman A, Andersson E, Nordfors C, Grün N, Johansson H, Munck-Wikland E, Massucci G,
Dalianis T, Ramqvist T. Int J Cancer. 2013 Jan 1;132(1):72-81. MHC class I expression in
HPV positive and negative tonsillar squamous cell carcinoma in correlation to clinical
outcome.
Näsman A, Romanitan M, Nordfors C, Grün N, Johansson H, Hammarstedt L, Marklund L,
Munck-Wikland E, Dalianis T, Ramqvist T. PLoS One. 2012;7(6):e38711. Tumor infiltrating
CD8+ and Foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus
(HPV) status in tonsillar cancer.
Ståhlbom AK, Johansson H, Liljegren A, von Wachenfeldt A, Arver B.
Fam Cancer. 2012 Mar;11(1):33-40. Evaluation of the BOADICEA risk assessment model in
women with a family history of breast cancer.
Ahlberg A, Nikolaidis P, Engström T, Gunnarsson K, Johansson H, Sharp L, Laurell G.
Head Neck. 2012 Jan;34(1):66-72. Morbidity of supraomohyoidal and modified radical neck
dissection combined with radiotherapy for head and neck cancer: a prospective longitudinal
study.
3
Liljegren A, Gunnarsson P, Landgren BM, Robéus N, Johansson H, Rotstein S. Breast Cancer
Res Treat. 2012 Oct;135(3):791-8. Reducing vasomotor symptoms with acupuncture in breast
cancer patients treated with adjuvant tamoxifen: a randomized controlled trial.
Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L, Lee A,
Barrowdale D, Healey S, Sinilnikova OM, Caligo MA, Loman N, Harbst K, Lindblom A,
Arver B, Rosenquist R, Karlsson P, et al. Breast Cancer Res. 2012 Feb 20;14(1):R33.
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast
cancer risk for BRCA1 and/or BRCA2 mutation carriers.
Bergh J, Mariani G, Cardoso F, Liljegren A, Awada A, Viganò L, Huang X, Verkh L, Kern
KA, Giorgetti C, Gianni L. Clinical and pharmacokinetic study of sunitinib and docetaxel in
women with advanced breast cancer. Breast. 2012 Aug;21(4):507-13. doi:
10.1016/j.breast.2012.01.012. Epub 2012 Feb 14.
Bergh J, Bondarenko IM, Lichinitser MR, Liljegren A, Greil R, Voytko NL, Makhson AN,
Cortes J, Lortholary A, Bischoff J, Chan A, Delaloge S, Huang X, Kern KA, Giorgetti C.
J Clin Oncol. 2012 Mar 20;30(9):921-9. doi: 10.1200/JCO.2011.35.7376. Epub 2012 Feb 13.
First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel
versus docetaxel alone: results of a prospective, randomized phase III study.
Ramus SJ, Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L,
Sinilnikova OM, Healey S, Barrowdale D, Lee A, Thomassen M, Gerdes AM, Kruse TA,
Jensen UB, Skytte AB, Caligo MA, Liljegren A, Lindblom A, Olsson H, Kristoffersson U,
Stenmark-Askmalm M, Melin B, et al. Hum Mutat. 2012 Apr;33(4):690-702. Ovarian cancer
susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.
2011
Brandberg Y, Aamdal S, Bastholt L, Hernberg M, Stierner U, von der Maase H, Hansson J.
Health-related quality of life in patients with high-risk melanoma randomised in the Nordic
phase 3 trial with adjuvant intermediate-dose interferon alfa-2b. Eur J Cancer. 2011 Dec 22.
[Epub ahead of print]
Hatschek T, Carlsson L, Einbeigi Z, Lidbrink E, Linderholm B, Lindh B, Loman N,
Malmberg M, Rotstein S, Söderberg M, Sundquist M, Walz TM, Hellström M, Svensson H,
Aström G, Brandberg Y, Carstensen J, Fernö M, Bergh J. Individually tailored treatment with
epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic
breast cancer: a randomized multicenter trial. Breast Cancer Res Treat. 2011[Epub ahead of
print]
Brandberg Y, Arver B, Johansson H, Wickman M, Sandelin K, Liljegren A. Less
correspondence between expectations before and cosmetic results after risk-reducing
mastectomy in women who are mutation carriers: A prospective study. Eur J Surg Oncol.
2011. [Epub ahead of print]
Unukovych D, Khrapach V, Wickman M, Liljegren A, Mishalov V, Patlazhan G, Sandelin K.
Polyacrylamide Gel Injections for Breast Augmentation: Management of Complications in
106 Patients, a Multicenter Study. World J Surg. 2011; Apr;36(4):695-701
4
Arver B, Isaksson K, Atterhem H, Baan A, Bergkvist L, Brandberg Y, Ehrencrona H,
Emanuelsson M, Hellborg H, Henriksson K, Karlsson P, Loman N, Lundberg J, Ringberg A,
Askmalm MS, Wickman M, Sandelin K. Bilateral prophylactic mastectomy in Swedish
women at high risk of breast cancer: a national survey. Ann Surg. 2011; 253: 1147-54.
Iiristo M, Wiklund T, Wilking N, Bergh J, Brandberg Y. Tailored chemotherapy doses based
on toxicity in breast cancer result in similar quality of life values, irrespective of given dose
levels. Acta Oncol. 2011; 50: 338-43.
Hansson J, Aamdal S, Bastholt L, Brandberg Y, Hernberg M, Nilsson B, Stierner U, von der
Maase H; Nordic Melanoma Cooperative Group. Two different durations of adjuvant therapy
with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN
trial): a randomised phase 3 trial. Lancet Oncol. 2011; 12: 144-52.
Wahlgren T, Levitt S, Kowalski J, Nilsson S, Brandberg Y. Use of the Charlson combined
comorbidity index to predict postradiotherapy quality of life for prostate cancer patients. Int J
Radiat Oncol Biol Phys. 2011; 81: 997-1004.
Wasteson E, Sandelin K, Brandberg Y, Wickman M, Arver B. High satisfaction rate ten years
after bilateral prophylactic mastectomy - a longitudinal study. Eur J Cancer Care. 2011; 20:
508-13.
Arraras JI, Greimel E, Chie WC, Sezer O, Bergenmar M, Costantini A, Young T, Vlasic KK,
Velikova G; on behalf of the European Organisation for Research and Treatment of Cancer
Quality of Life Group. Cross-cultural differences in information disclosure evaluated through
the EORTC questionnaires. Psychooncology. 2011 [Epub ahead of print]
Sharp L, Johansson H, Landin Y, Moegelin IM, Bergenmar M. Frequency and severity of
skin reactions in patients with breast cancer undergoing adjuvant radiotherapy, the usefulness
of two assessment instruments - A pilot study. Eur J Cancer. 2011 Dec;47(18):2665-72
Arraras JI, Greimel E, Chie WC, Sezer O, Bergenmar M, Costantini A, Young T, Kuljanic K,
Velikova G; European Organisation for Research and Treatment of Cancer Quality of Life
Group. Information disclosure to cancer patients: EORTC QLQ-INFO25 questionnaire.
Expert Rev Pharmacoecon Outcomes Res. 2011; 11: 281-6.
Hellbom M, Bergelt C, Bergenmar M, Gijsen B, Loge JH, Rautalahti M, Smaradottir A,
Johansen C. Cancer rehabilitation: A Nordic and European perspective. Acta Oncol. 2011; 50:
179-86.
Bergenmar M, Johansson H, Wilking N. Levels of knowledge and perceived understanding
among participants in cancer clinical trials - factors related to the informed consent procedure.
Clin Trials. 2011; 8: 77-84.
Mulligan AM, Couch FJ, Barrowdale D, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ,
Robson M, Sherman M, Spurdle AB, Wappenschmidt B, Lee A et al. Common breast cancer
susceptibility alleles are associated with tumor subtypes in BRCA1 and BRCA2 mutation
carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Breast
5
Cancer Res. 2011 [Epub ahead of print]
Antoniou AC, Kartsonaki C, Sinilnikova OM, Soucy P, McGuffog L, Healey S, Lee A,
Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Cattaneo E, Barile M, Pensotti V, Pasini
B, Dolcetti R, Giannini G, Putignano AL, Varesco L, Radice P, Mai PL, Greene MH,
Andrulis IL, Glendon G, Ozcelik H, Thomassen M, Gerdes AM, Kruse TA, Birk Jensen U,
Crüger DG, Caligo MA, Laitman Y, Milgrom R, Kaufman B, Paluch-Shimon S, Friedman E,
Loman N, Harbst K, Lindblom A, Arver B, Ehrencrona H, Melin B et al.. Common alleles at
6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation
carriers. Hum Mol Genet. 2011; 20: 3304-21.
Ramus SJ, Kartsonaki C, Gayther SA, Pharoah PD, Sinilnikova OM, Beesley J, Chen X,
McGuffog L, Healey S, Couch FJ, Wang X, Fredericksen Z, Peterlongo P, Manoukian S,
Peissel B, Zaffaroni D, Roversi G, Barile M, Viel A, Allavena A, Ottini L, Papi L, Gismondi
V, Capra F, Radice P, Greene MH, Mai PL, Andrulis IL, Glendon G, Ozcelik H; OCGN,
Thomassen M, Gerdes AM, Kruse TA, Cruger D, Jensen UB, Caligo MA, Olsson H,
Kristoffersson U, Lindblom A, Arver B, Karlsson P, Stenmark Askmalm M, Borg A et al.
Consortium of Investigators of Modifiers of BRCA1/2. Genetic variation at 9p22.2 and
ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst. 2011; 103:
105-16.
Bränström R, Kvillemo P, Moskowitz JT. A Randomized Study of the Effects of Mindfulness
Training on Psychological Well-being and Symptoms of Stress in Patients Treated for Cancer
at 6-month Follow-up. Int J Behav Med. 2011. [Epub ahead of print]
Bränström R, Duncan LG, Moskowitz JT. The association between dispositional mindfulness,
psychological well-being, and perceived health in a Swedish population-based sample. Br J
Health Psychol. 2011; 16: 300-16.
Kvillemo P, Bränström R. Experiences of a mindfulness-based stress-reduction intervention
among patients with cancer. Cancer Nurs. 2011 Jan-Feb;34(1):24-31.
Colzani E, Liljegren A, Johansson AL, Adolfsson J, Hellborg H, Hall PF, Czene K. Prognosis
of patients with breast cancer: causes of death and effects of time since diagnosis, age, and
tumor characteristics. J Clin Oncol. 2011; 29: 4014-21.
Osorio A, Milne RL, Alonso R, Pita G, Peterlongo P, Teulé A, Nathanson KL, Domchek SM,
Rebbeck T, Lasa A, Konstantopoulou I, Hogervorst FB, Verhoef S, van Dooren MF, Jager A,
Ausems MG, Aalfs CM, van Asperen CJ, Vreeswijk M, Waisfisz Q, Van Roozendaal CE,
Ligtenberg MJ; HEBON; EMBRACE, Easton DF, Peock S, Cook M, Oliver CT, Frost D,
Curzon B, Evans DG, Lalloo F, Eeles R, Izatt L, Davidson R, Adlard J, Eccles D, Ong KR,
Douglas F, Downing S, Brewer C, Walker L, Nevanlinna H, Aittomäki K, Couch FJ,
Fredericksen Z, Lindor NM, Godwin A, Isaacs C, Caligo MA, Loman N, Jernström H,
Barbany-Bustinza G, Liljegren A, Ehrencrona H, Stenmark-Askmalm M et al. Evaluation of
the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the
consortium of investigators of modifiers of BRCA1/BRCA2. Br J Cancer. 2011; 104:1356-61.
Spurdle AB, Marquart L, McGuffog L, Healey S, Sinilnikova O, Wan F, Chen X, Beesley J,
Singer CF, Dressler AC, Gschwantler-Kaulich D, Blum JL, Tung N, Weitzel J, Lynch H,
Garber J, Easton DF, Peock S, Cook M, Oliver CT, Frost D, Conroy D, Evans DG, Lalloo F,
6
Eeles R, Izatt L, Davidson R, Chu C, Eccles D, Selkirk CG, Daly M, Isaacs C, StoppaLyonnet D, Sinilnikova OM, Buecher B, Belotti M, Mazoyer S, Barjhoux L, Verny-Pierre C,
Lasset C, Dreyfus H, Pujol P, Collonge-Rame MA; GEMO Study Collaborators, Rookus MA,
Verhoef S, Kriege M, Hoogerbrugge N, Ausems MG, van Os TA, Wijnen J, Devilee P,
Meijers-Heijboer HE, Blok MJ, Heikkinen T, Nevanlinna H, Jakubowska A, Lubinski J,
Huzarski T, Byrski T, Durocher F, Couch FJ, Lindor NM, Wang X, Thomassen M, Domchek
S, Nathanson K, Caligo M, Jernström H, Liljegren A, Ehrencrona H, Karlsson P; SWEBRCA, Ganz PA, Olopade OI, Tomlinson G, Neuhausen S, Antoniou AC, Chenevix-Trench
G, Rebbeck TR. Common genetic variation at BARD1 is not associated with breast cancer
risk in BRCA1 or BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev. 2011; 20:
1032-8.
Fahlén M, Wallberg B, von Schoultz E, Carlström K, Svensson G, Wilking N, Brandberg Y.
Health-related quality of life during hormone therapy after breast cancer: a randomized trial.
Climacteric. 2011 Feb;14(1):164-70.
Sverrisdottir A, Johansson H, Johansson U, Bergh J, Rotstein S, Rutqvist L,
Fornander T. Interaction between goserelin and tamoxifen in a prospective randomised
clinical trial of adjuvant endocrine therapy in premenopausal breast cancer. Breast Cancer Res
Treat. 2011; 128: 755-63.
Ahlberg A, Engström T, Nikolaidis P, Gunnarsson K, Johansson H, Sharp L, Laurell
G. Early self-care rehabilitation of head and neck cancer patients.mBreast Cancer Res Treat.
2011; 128: 755-63. Acta Otolaryngol. 2011; 131: 552-61.
Wilking U, Karlsson E, Skoog L, Hatschek T, Lidbrink E, Elmberger G, Johansson
H, Lindström L, Bergh J. HER2 status in a population-derived breast cancer cohort:
discordances during tumor progression.Breast Cancer Res Treat. 2011; 125: 553-61.
7
2010
Svensson H, Einbeigi Z, Johansson H, Hatschek T, Brandberg Y. Quality of life in women
with metastatic breast cancer during 9 months after randomization in the TEX trial (epirubicin
and paclitaxel w/o capecitabine). Breast Cancer Res Treat. 2010; 123: 785-93.
Bränström R, Kasparian NA, Chang YM, Affleck P, Tibben A, Aspinwall LG, Azizi E,
Baron-Epel O, Battistuzzi L, Bergman W, Bruno W, Chan M, Cuellar F, Debniak T, Pjanova
D, Ertmanski S, Figl A, Gonzalez M, Hayward NK, Hocevar M, Kanetsky PA, Leachman SA,
Heisele O, Palmer J, Peric B, Puig S, Schadendorf D, Gruis NA, Newton-Bishop J, Brandberg
Y. Predictors of sun protection behaviors and severe sunburn in an international online study.
Cancer Epidemiol Biomarkers Prev. 2010; 19: 2199-210.
Gahm J, Wickman M, Brandberg Y. Bilateral prophylactic mastectomy in women with
inherited risk of breast cancer--prevalence of pain and discomfort, impact on sexuality,
quality of life and feelings of regret two years after surgery. Breast. 2010; 19: 462-9.
Sackey H, Sandelin K, Frisell J, Wickman M, Brandberg Y. Ductal carcinoma in situ of the
breast. Long-term follow-up of health-related quality of life, emotional reactions and body
image. Eur J Surg Oncol. 2010; 36: 756-62.
Bergenmar M, Månsson-Brahme E, Hansson J, Brandberg Y. Surgical resection margins do
not influence health related quality of life or emotional distress in patients with cutaneous
melanoma: results of a prospective randomised trial. Scand J Plast Reconstr Surg Hand Surg.
2010; 44: 146-55.
Bränström R, Kvillemo P, Brandberg Y, Moskowitz JT. Self-report mindfulness as a mediator
of psychological well-being in a stress reduction intervention for cancer patients--a
randomized study. Ann Behav Med. 2010 ;39: 151-61.
Bränström R, Chang YM, Kasparian N, Affleck P, Tibben A, Aspinwall LG, Azizi E, BaronEpel O, Battistuzzi L, Bruno W, Chan M, Cuellar F, Debniak T, Pjanova D, Ertmański S, Figl
A, Gonzalez M, Hayward NK, Hocevar M, Kanetsky PA, Leaf SL, van Nieuwpoort FA,
Heisele O, Palmer J, Peric B, Puig S, Ruffin AD, Schadendorf D, Gruis NA, Brandberg Y,
Newton-Bishop J. Melanoma risk factors, perceived threat and intentional tanning: an
international online survey. Eur J Cancer Prev. 2010; 19: 216-26.
Bränström R, Brandberg Y. Health risk perception, optimistic bias, and personal satisfaction.
Am J Health Behav. 2010; 34: 197-205.
Bränström R, Penilla C, Pérez-Stable EJ, Muñoz RF. Positive affect and mood management
in successful smoking cessation. Am J Health Behav. 2010; 34: 553-62.
Bränström R, Duncan LG, Moskowitz JT. The association between dispositional mindfulness,
psychological well-being, and perceived health in a Swedish population-based sample. Br J
Health Psychol. 2010. [Epub ahead of print]
Liljegren A, Gunnarsson P, Landgren BM, Robéus N, Johansson H, Rotstein S. Reducing
vasomotor symptoms with acupuncture in breast cancer patients treated with adjuvant
8
tamoxifen: a randomized controlled trial. Breast Cancer Res Treat. 2010. [Epub ahead of
print]
Walker LC, Fredericksen ZS, Wang X, Tarrell R, Pankratz VS, Lindor NM, Beesley J,
Healey S, Chen X; kConFab, Stoppa-Lyonnet D, Tirapo C, Giraud S, Mazoyer S, Muller D,
Fricker JP, Delnatte C; GEMO Study Collaborators, Schmutzler RK, Wappenschmidt B,
Engel C, Schönbuchner I, Deissler H, Meindl A, Hogervorst FB, Verheus M, Hooning MJ,
van den Ouweland AM, Nelen MR, Ausems MG, Aalfs CM, van Asperen CJ, Devilee P,
Gerrits MM, Waisfisz Q; HEBON, Szabo CI; ModSQuaD, Easton DF, Peock S, Cook M,
Oliver CT, Frost D, Harrington P, Evans DG, Lalloo F, Eeles R, Izatt L, Chu C, Davidson R,
Eccles D, Ong KR, Cook J; EMBRACE, Rebbeck T, Nathanson KL, Domchek SM, Singer
CF, Gschwantler-Kaulich D, Dressler AC, Pfeiler G, Godwin AK, Heikkinen T, Nevanlinna
H, Agnarsson BA, Caligo MA, Olsson H, Kristoffersson U, Liljegren A, Arver B, Karlsson P,
Melin B; SWE-BRCA, Sinilnikova OM, McGuffog L, Antoniou AC, Chenevix-Trench G,
Spurdle AB, Couch FJ. Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2
mutation carriers. Breast Cancer Res. 2010; 12: R102.
Engel C, Versmold B, Wappenschmidt B, Simard J, Easton DF, Peock S, Cook M, Oliver C,
Frost D, Mayes R, Evans DG, Eeles R, Paterson J, Brewer C; Epidemiological Study of
Familial Breast Cancer (EMBRACE), McGuffog L, Antoniou AC, Stoppa-Lyonnet D,
Sinilnikova OM, Barjhoux L, Frenay M, Michel C, Leroux D, Dreyfus H, Toulas C, Gladieff
L, Uhrhammer N, Bignon YJ, Meindl A, Arnold N, Varon-Mateeva R, Niederacher D,
Preisler-Adams S, Kast K, Deissler H, Sutter C, Gadzicki D, Chenevix-Trench G, Spurdle AB,
Chen X, Beesley J; Kathleen Cuningham Foundation Consortium for Research into Familial
Breast Cancer (kConFab), Olsson H, Kristoffersson U, Ehrencrona H, Liljegren A; Swedish
Breast Cancer Study, Sweden (SWE-BRCA), van der Luijt RB, van Os TA, van Leeuwen FE;
Hereditary Breast and Ovarian cancer group Netherlands (HEBON), Domchek SM, Rebbeck
TR, Nathanson KL, Osorio A, Ramón y Cajal T, Konstantopoulou I, Benítez J, Friedman E,
Kaufman B, Laitman Y, Mai PL, Greene MH, Nevanlinna H, Aittomäki K, Szabo CI, Caldes
T, Couch FJ, Andrulis IL, Godwin AK, Hamann U, Schmutzler RK; Consortium of
Investigators of Modifiers of BRCA1/2 (CIMBA). Association of the variants CASP8 D302H
and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation
carriers. Cancer Epidemiol Biomarkers Prev. 2010; 19:2859-68.
Arraras JI, Greimel E, Sezer O, Chie WC, Bergenmar M, Costantini A, Young T, Vlasic KK,
Velikova G. An international validation study of the EORTC QLQ-INFO25 questionnaire: an
instrument to assess the information given to cancer patients. Eur J Cancer. 2010; 46: 2726-38.
2009
Von Wachenfeldt A, Brandberg Y, Johansson H, Fornander T. Socioeconomic status and
quality of life of women with family history of breast cancer attending an oncogenetic
counseling clinic: a comparison with general population. Acta Oncol. 2009; 48: 86-92.
Rantala J, Platten U, Lindgren G, Nilsson B, Arver B, Lindblom A, Brandberg Y. Risk
perception after genetic counseling in patients with increased risk of cancer. Hered Cancer
Clin Pract. 2009; 7:15.
Bergenmar M, Hansson J, Brandberg Y. Family members' perceptions of genetic testing for
malignant melanoma--a prospective interview study. Eur J Oncol Nurs. 2009; 13: 74-80.
9
Osorio A, Milne RL, Pita G, Peterlongo P, Heikkinen T, Simard J, Chenevix-Trench G,
Spurdle AB, Beesley J, Chen X, Healey S; KConFab, Neuhausen SL, Ding YC, Couch FJ,
Wang X, Lindor N, Manoukian S, Barile M, Viel A, Tizzoni L, Szabo CI, Foretova L, Zikan
M, Claes K, Greene MH, Mai P, Rennert G, Lejbkowicz F, Barnett-Griness O, Andrulis IL,
Ozcelik H, Weerasooriya N; OCGN, Gerdes AM, Thomassen M, Cruger DG, Caligo MA,
Friedman E, Kaufman B, Laitman Y, Cohen S, Kontorovich T, Gershoni-Baruch R, Dagan E,
Jernström H, Askmalm MS, Arver B, Malmer B; SWE-BRCA, Domchek SM, Nathanson KL,
Brunet J, Ramón Y Cajal T, Yannoukakos D, Hamann U; HEBON, Hogervorst FB, Verhoef
S, Gómez García EB, Wijnen JT, van den Ouweland A; EMBRACE, Easton DF, Peock S,
Cook M, Oliver CT, Frost D, Luccarini C, Evans DG, Lalloo F, Eeles R, Pichert G, Cook J,
Hodgson S, Morrison PJ, Douglas F, Godwin AK; GEMO, Sinilnikova OM, Barjhoux L,
Stoppa-Lyonnet D, Moncoutier V, Giraud S, Cassini C, Olivier-Faivre L, Révillion F, Peyrat
JP, Muller D, Fricker JP, Lynch HT, John EM, Buys S, Daly M, Hopper JL, Terry MB, Miron
A, Yassin Y, Goldgar D; Breast Cancer Family Registry, Singer CF, Gschwantler-Kaulich D,
Pfeiler G, Spiess AC, Hansen TV, Johannsson OT, Kirchhoff T, Offit K, Kosarin K,
Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV,
Toland AE, Montagna M, Casella C, Imyanitov EN, Allavena A, Schmutzler RK, Versmold
B, Engel C, Meindl A, Ditsch N, Arnold N, Niederacher D, Deissler H, Fiebig B, VaronMateeva R, Schaefer D, Froster UG, Caldes T, de la Hoya M, McGuffog L, Antoniou AC,
Nevanlinna H, Radice P, Benítez J; CMBA. Evaluation of a candidate breast cancer
associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers.
Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA). Br J
Cancer. 2009; 101: 2048-54.
Liljegren A, Bergh J, Castany R. Early experience with sunitinib, combined with docetaxel, in
patients with metastatic breast cancer. Breast. 2009; 18: 259-62.
Weber G, Chamorro CI, Granath F, Liljegren A, Zreika S, Saidak Z, Sandstedt B, Rotstein S,
Mentaverri R, Sánchez F, Pivarcsi A, Ståhle M. Human antimicrobial protein hCAP18/LL-37
promotes a metastatic phenotype in breast cancer. Breast Cancer Res. 2009; 11:R6
Antoniou AC, Rookus M, Andrieu N, Brohet R, Chang-Claude J, Peock S, Cook M, Evans
DG, Eeles R; EMBRACE, Nogues C, Faivre L, Gesta P; GENEPSO, van Leeuwen FE,
Ausems MG, Osorio A; GEO-HEBON, Caldes T, Simard J, Lubinski J, Gerdes AM, Olah E,
Fürhauser C, Olsson H, Arver B, Radice P, Easton DF, Goldgar DE. Reproductive and
hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results
from the International BRCA1/2 Carrier Cohort Study. Cancer Epidemiol Biomarkers Prev.
2009; 18: 601-10.
Randén M, Rutqvist LE, Johansson H. Cancer patients without a known primary: incidence
and survival trends in Sweden 1960-2007. Acta Oncol. 2009; 48: 915-20.
Sverrisdottir A, Nystedt M, Johansson H, Fornander T. Adjuvant goserelin and ovarian
preservation in chemotherapy treated patients with early breast cancer: results from a
randomized trial. Breast Cancer Res Treat. 2009; 117: 561-7.
2008
Johansson B, Brandberg Y, Hellbom M, Persson C, Petersson LM, Berglund G, Glimelius B.
10
Health-related quality of life and distress in cancer patients: results from a large randomised
study. Br J Cancer. 2008; 99: 1975-83.
Svensson H, Brandberg Y, Einbeigi Z, Hatschek T, Ahlberg K. Psychological Reactions to
Progression of Metastatic Breast Cancer-An Interview Study. Cancer Nurs. 2008 Oct 8. [Epub
ahead of print]
Bergenmar M, Molin C, Wilking N, Brandberg Y. Knowledge and understanding among
cancer patients consenting to participate in clinical trials. Eur J Cancer. 2008; 44: 2627-33.
2008; 44: 2627-33.
Brandberg Y, Sandelin K, Erikson S, Jurell G, Liljegren A, Lindblom A, Lindén A, von
Wachenfeldt A, Wickman M, Arver B. Psychological reactions, quality of life, and body
image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a
prospective 1-year follow-up study. J Clin Oncol. 2008 20; 26: 3943-9.
Jayasekara H, Rajapaksa LC, Brandberg Y. Measuring breast cancer-specific health-related
quality of life in South Asia: psychometric properties of the Sinhala version of the EORTC
QLQ-BR23. Qual Life Res. 2008; 17: 927-32.
Arving C, Glimelius B, Brandberg Y. Four weeks of daily assessments of anxiety, depression
and activity compared to a point assessment with the Hospital Anxiety and Depression Scale.
Qual Life Res. 2008; 1: 95-104.
Bränström R, Andréasson S. Regional differences in alcohol consumption, alcohol addiction
and drug use among Swedish adults. Scand J Public Health. 2008; 36: 493-503.
Bränström R, Sjöström E, Andréasson S. Individual, group and community risk and protective
factors for alcohol and drug use among Swedish adolescents. Eur J Public Health. 2008;
18:12-8.
Tishelman C, Bergenmar M, Bernhardson BM, Blomberg K, Börjeson S, Foderus H,
Leveälahti H, Sahlberg-Blom E, Ternestedt BM. Using undergraduate nursing students as
mediators in a knowledge transfer programme for care for patients with advanced cancer. Eur
J Cancer Care (Engl). 2008; 17:253-60.
Liljegren A, Barker G, Elliott F, Bertario L, Bisgaard ML, Eccles D, Evans G, Macrae F,
Maher E, Lindblom A, Rotstein S, Nilsson B, Mecklin JP, Möslein G, Jass J, Fodde R,
Mathers J, Burn J, Bishop DT. Prevalence of adenomas and hyperplastic polyps in mismatch
repair mutation carriers among CAPP2 participants: report by the colorectal
adenoma/carcinoma prevention programme 2. J Clin Oncol. 2008; 26: 3434-9.
Arriagada R, Rutqvist LE, Johansson H, Kramar A, Rotstein S Predicting distant
dissemination in patients with early breast cancer. Acta Oncol. 2008; 47: 1113-21.
Sharp L, Johansson H, Fagerström K, Rutqvist LE. Smoking cessation among patients with
head and neck cancer: cancer as a 'teachable moment'. Eur J Cancer Care (Engl). 2008; 17:
114-9.
Khoshnoud MR, Fornander T, Johansson H, Rutqvist LE. Long-term pattern of disease
11
recurrence among patients with early-stage breast cancer according to estrogen receptor status
and use of adjuvant tamoxifen. Breast Cancer Res Treat. 2008; 107: 71-8.
2007
Bremberg ER, Brandberg Y, Hising C, Friesland S, Eksborg S. Anemia and quality of life
including anemia-related symptoms in patients with solid tumors in clinical practice. Med
Oncol. 2007; 24: 95-102.
Arving C, Sjödén PO, Bergh J, Hellbom M, Johansson B, Glimelius B, Brandberg Y.
Individual psychosocial support for breast cancer patients: a randomized study of nurse versus
psychologist interventions and standard care. Cancer Nurs. 2007; 30: E10-9.
Wahlgren T, Nilsson S, Lennernäs B, Brandberg Y. Promising long-term health-related
quality of life after high-dose-rate brachytherapy boost for localized prostate cancer. Int J
Radiat Oncol Biol Phys. 2007; 69: 662-70.
Andréasson S, Sjöström E, Bränström R. A six-community prevention trial to reduce alcohol
and drug use-related problems in Sweden: planning and early findings. Subst Use Misuse.
2007; 42: 2017-27.
Hansson J, Bergenmar M, Hofer PA, Lundell G, Månsson-Brahme E, Ringborg U, Synnerstad
I, Bratel AT, Wennberg AM, Rosdahl I. Monitoring of kindreds with hereditary
predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish
preventive program. J Clin Oncol. 2007; 25: 2819-24.
Rutqvist LE, Johansson H. Stockholm Breast Cancer Study Group. Long-term follow-up of
the randomized Stockholm trial on adjuvant tamoxifen among postmenopausal patients with
early stage breast cancer. Acta Oncol. 2007; 46: 133-45.
Johnsson A, Fornander T, Olsson M, Nystedt M, Johansson H, Rutqvist LE. Factors
associated with return to work after breast cancer treatment. Acta Oncol. 2007; 46: 90
2006
Bergenmar M, Nylén U, Lidbrink E, Bergh J, Brandberg Y. Improvements in patient
satisfaction at an outpatient clinic for patients with breast cancer. Acta Oncol. 2006; 45: 550-8.
Samuelsson J, Hasselbalch H, Bruserud O, Temerinac S, Brandberg Y, Merup M, Linder O,
Bjorkholm M, Pahl HL, Birgegard G; Nordic Study Group for Myeloproliferative Disorders.
A phase II trial of pegylated interferon alpha-2b therapy for polycythemia vera and essential
thrombocythemia: feasibility, clinical and biologic effects, and impact on quality of life.
Cancer. 2006; 106: 2397-405.
Arving C, Sjödén PO, Bergh J, Lindström AT, Wasteson E, Glimelius B, Brandberg Y.
Satisfaction, utilisation and perceived benefit of individual psychosocial support for breast
cancer patients--a randomised study of nurse versus psychologist interventions. Patient Educ
Couns. 2006; 62: 235-43.
Petersen MA, Groenvold M, Aaronson N, Blazeby J, Brandberg Y, de Graeff A, Fayers P,
12
Hammerlid E, Sprangers M, Velikova G, Bjorner JB; European Organisation for Research
and Treatment of Cancer Quality of Life Group.Item response theory was used to shorten
EORTC QLQ-C30 scales for use in palliative care. J Clin Epidemiol. 2006; 59: 36-44.
Azocar F, Branstrom RB. Use of depression education materials to improve treatment
compliance of primary care patients. J Behav Health Serv Res. 2006; 33: 347-53.
Bränström R, Kristjansson S, Dal H, Rodvall Y. Sun exposure and sunburn among Swedish
toddlers. Eur J Cancer. 2006; 42: 1441-7.
Bränström R, Kristjansson S, Ullén H. Risk perception, optimistic bias, and readiness to
change sun related behaviour. Eur J Public Health. 2006; 16: 492-7.
Andrieu N, Goldgar DE, Easton DF, Rookus M, Brohet R, Antoniou AC, Peock S, Evans G,
Eccles D, Douglas F, Noguès C, Gauthier-Villars M, Chompret A, Van Leeuwen FE, Kluijt I,
Benitez J, Arver B, Olah E, Chang-Claude J; EMBRACE; GENEPSO; GEO-HEBON;
IBCCS Collaborators Group. Pregnancies, breast-feeding, and breast cancer risk in the
International BRCA1/2 Carrier Cohort Study (IBCCS). J Natl Cancer Inst. 2006 Apr
19;98(8):535-44.
Westman B, Bergenmar M, Andersson L. Life, illness and death--existential reflections of a
Swedish sample of patients who have undergone curative treatment for breast or prostatic
cancer. Eur J Oncol Nurs. 2006; 10: 169-76.
He Q, Fornander T, Johansson H, Johansson U, Hu GZ, Rutqvist LE, Skog S. Thymidine
kinase 1 in serum predicts increased risk of distant or loco-regional recurrence following
surgery in patients with early breast cancer. Anticancer Res. 2006; 26 :4753-9.
Rutqvist LE, Johansson H. Long-term follow-up of the Stockholm randomized trials of
postoperative radiation therapy versus adjuvant chemotherapy among 'high risk' pre- and
postmenopausal breast cancer patients. Acta Oncol. 2006; 45: 517-27.
Margolin S, Johansson H, Rutqvist LE, Lindblom A, Fornander T. Family history, and impact
on clinical presentation and prognosis, in population-based breast cancer cohort from the
Stockholm County. Fam Cancer. 2006; 5:309-21.